SOMATOSTATINE RECEPTOR SUBTYPE 1 (SSTR1) ACTIVE COMPOUNDS AND THEIR USE IN THERAPY

摘要

This invention relates to a group of novel somatostatin receptor subtype 1 (SSTR1) active compounds and pharmaceutical compositions comprising said compounds. Furthermore, the invention concerns the use of said compounds for the treatment or prevention of diseases or conditions responding to SSTR1 active compounds. Moreover, the invention concerns methods of targeting a tissue bearing SSTR1s either for tissue imaging or as carriers for drugs to be transported to said tissue.